LU84860A1 - Nouveau derive de la pyrazolo(1,5-a)pyridine,sa preparation et les compositions pharmaceutiques qui le contiennent - Google Patents

Nouveau derive de la pyrazolo(1,5-a)pyridine,sa preparation et les compositions pharmaceutiques qui le contiennent Download PDF

Info

Publication number
LU84860A1
LU84860A1 LU84860A LU84860A LU84860A1 LU 84860 A1 LU84860 A1 LU 84860A1 LU 84860 A LU84860 A LU 84860A LU 84860 A LU84860 A LU 84860A LU 84860 A1 LU84860 A1 LU 84860A1
Authority
LU
Luxembourg
Prior art keywords
formula
pyrazolo
pyridine
preparation
compositions
Prior art date
Application number
LU84860A
Other languages
English (en)
French (fr)
Inventor
Raymond Frederick Collins
Libert Clinton Saunders
Peter James Warne
Christopher Antony Ramsden
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of LU84860A1 publication Critical patent/LU84860A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU84860A 1982-06-16 1983-06-15 Nouveau derive de la pyrazolo(1,5-a)pyridine,sa preparation et les compositions pharmaceutiques qui le contiennent LU84860A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8217485 1982-06-16
GB8217485 1982-06-16

Publications (1)

Publication Number Publication Date
LU84860A1 true LU84860A1 (fr) 1984-03-07

Family

ID=10531092

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84860A LU84860A1 (fr) 1982-06-16 1983-06-15 Nouveau derive de la pyrazolo(1,5-a)pyridine,sa preparation et les compositions pharmaceutiques qui le contiennent

Country Status (21)

Country Link
US (1) US4604400A (OSRAM)
JP (1) JPS595185A (OSRAM)
KR (1) KR840005139A (OSRAM)
AT (1) AT381312B (OSRAM)
AU (1) AU556031B2 (OSRAM)
BE (1) BE897068A (OSRAM)
CH (1) CH658053A5 (OSRAM)
DE (1) DE3321674A1 (OSRAM)
DK (1) DK275083A (OSRAM)
ES (1) ES8500274A1 (OSRAM)
FI (1) FI832173A7 (OSRAM)
FR (1) FR2528846B1 (OSRAM)
GR (1) GR79314B (OSRAM)
HU (1) HU187922B (OSRAM)
IL (1) IL68996A0 (OSRAM)
IT (1) IT1169734B (OSRAM)
LU (1) LU84860A1 (OSRAM)
NL (1) NL8302134A (OSRAM)
NZ (1) NZ204589A (OSRAM)
SE (1) SE8303435L (OSRAM)
ZA (1) ZA834408B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925849A (en) * 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
GB8901423D0 (en) * 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
EP3406607A1 (en) 2012-12-21 2018-11-28 Epizyme, Inc. Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
US9365555B2 (en) 2012-12-21 2016-06-14 Epizyme, Inc. PRMT5 inhibitors and uses thereof
JP2016505597A (ja) 2012-12-21 2016-02-25 エピザイム，インコーポレイティド Ｐｒｍｔ５阻害剤およびその使用
US9908887B2 (en) 2012-12-21 2018-03-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
RS58040B1 (sr) 2012-12-21 2019-02-28 Epizyme Inc Prmt5 inhibitori i njihove upotrebe
CA2953572A1 (en) 2014-08-04 2016-02-11 Epizyme, Inc. Prmt5 inhibitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154583A (en) * 1974-11-01 1976-05-13 Kyorin Seiyaku Kk Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
JPS5610114A (en) * 1979-07-05 1981-02-02 Grelan Pharmaceut Co Ltd Novel analgesic and anti-inflammatory agent
JPS5651478A (en) * 1979-10-02 1981-05-09 Grelan Pharmaceut Co Ltd 3-carbamoyl-pyrazolo 1,5-a pyridine and its preparation

Also Published As

Publication number Publication date
ATA221183A (de) 1986-02-15
JPS595185A (ja) 1984-01-12
CH658053A5 (fr) 1986-10-15
IT8321635A0 (it) 1983-06-15
ZA834408B (en) 1984-03-28
DK275083D0 (da) 1983-06-15
FI832173L (fi) 1983-12-17
FR2528846B1 (fr) 1986-08-22
GR79314B (OSRAM) 1984-10-22
DK275083A (da) 1983-12-17
IT1169734B (it) 1987-06-03
SE8303435D0 (sv) 1983-06-15
SE8303435L (sv) 1983-12-17
US4604400A (en) 1986-08-05
FR2528846A1 (fr) 1983-12-23
NL8302134A (nl) 1984-01-16
AU556031B2 (en) 1986-10-16
BE897068A (fr) 1983-12-16
FI832173A0 (fi) 1983-06-15
FI832173A7 (fi) 1983-12-17
AT381312B (de) 1986-09-25
DE3321674A1 (de) 1983-12-22
HU187922B (en) 1986-03-28
ES523288A0 (es) 1984-10-01
NZ204589A (en) 1985-12-13
IL68996A0 (en) 1983-10-31
KR840005139A (ko) 1984-11-03
AU1577083A (en) 1983-12-22
ES8500274A1 (es) 1984-10-01

Similar Documents

Publication Publication Date Title
EP0201735B1 (de) N-Indolylethyl-sulfonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung
CH643546A5 (fr) Procede pour la preparation de derives d'hydantoine.
FR2663633A1 (fr) Nouvelles chalcones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CH655114A5 (fr) Derives de l'imidazotetrazinone, leur preparation et compositions pharmaceutiques les contenant.
EP0015038A1 (fr) Composition pharmaceutique comprenant un dérivé de diphénylhydantoine, dérivés mis en oeuvre et leur préparation
FR2498931A1 (fr) Medicament constitue par l'acide ethyl-1 fluoro-6 piperazinyl-7 oxo-4 dihydro-1,4 quinoleine-3 carboxylique et ses sels d'addition d'acides non toxiques pharmaceutiquement acceptables
LU84860A1 (fr) Nouveau derive de la pyrazolo(1,5-a)pyridine,sa preparation et les compositions pharmaceutiques qui le contiennent
LU83928A1 (fr) Acides amino-2 halogenobenzoyl-3 methyphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques
EP0113330B1 (fr) Composés énamides acylés, compositions pharmaceutiques les contenant, utilisation de ces composés et procédé de préparation de ces composés
FR2492821A1 (fr) Derives de la pyrimidine, leur procede de preparation et les compositions pharmaceutiques les contenant
BE1003692A4 (fr) Composes de pyrrolidinone et de piperidinone et compositions pharmaceutiques les contenant.
LU85690A1 (fr) Nouveaux derives de a pyrazolo (1,5-a) pyridine,leur preparation et les compositions therapeutiques qui les contiennent
FR2560197A1 (fr) Nouveaux derives de la pyrazolo(1,5-a)pyridine, leur preparation et les compositions pharmaceutiques qui les contiennent
CH646146A5 (fr) Derive du 1alpha,25-dihydroxy cholecalciferol et son procede de preparation.
FR2525218A1 (fr) Nouveaux derives du benzimidazole, leur preparation et les medicaments qui les contiennent
CA2015626A1 (fr) Derives benzothiazolinoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CH648295A5 (fr) Acides 2-amino-3-(alkylthiobenzyl)-phenylacetiques et leurs derives.
FR2495615A1 (fr) Ethers d'hydroxymethylpyrazines substituees, leur preparation et leur utilisation therapeutique en tant qu'agents antilipolytiques, hypotriglyceridemiques et hypocholesterolemiques
EP0120741B1 (fr) Nouveaux médicaments dérivés de la chloro-4 dithiole-1,2 one-3 et les compositions médicinales qui les contiennent
BE845074A (fr) Nouveaux agents antiinflammatoires imidazoles, leur preparation et compositions pharmaceutiques
FR2583047A1 (fr) Procede de preparation de derives du 4-phenylpropyl indole, et intermediaires
LU81892A1 (fr) Nouveaux dithiocarbamates, leur preparation et les medicaments qui les contiennent
EP0384812A1 (fr) Trifluorométhoxy-5 benzimidazolamine-2, procédé pour sa préparation et médicaments la contenant
EP0275221A2 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant
FR2563731A1 (fr) Composition therapeutique contenant de la 2-(n-phenylethyl-n-propylamino)-5-hydroxytetraline pour traiter la maladie de parkinson, pour stimuler selectivement les recepteurs de dopamine d-2 et procede de production d'une composition pharmaceutique utile au traitement de la maladie de parkinson